nanotech-investing Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
nanotech-investing Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells
nanotech-investing Longeveron® Granted Japan Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells
nanotech-investing Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs
nanotech-investing Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
nanotech-investing Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer
nanotech-investing Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property for Patent Covering Breast Cancer Vaccine Technology
nanotech-investing Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome
nanotech-investing Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine
nanotech-investing Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
nanotech-investing Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan
nanotech-investing Soleno Therapeutics Announces Select Preliminary Fourth Quarter and Full-Year 2025 Results
